Indianapolis, IN, United States of America

Leander Merritt

This inventor holds 21 USPTO granted patents and 1 EPO patent, primarily in Heterocyclic Compounds. Top assignee: Eli Lilly and Company. Active years: 1981-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Leander Merritt. Retrieved from https://idiyas.com/inventor/leander-merritt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 85.7


Average Co-Inventor Count = 3.3

ph-index = 5

Forward Citations = 57(Granted Patents)


Company Filing History:


Years Active: 1981-2010

Loading Chart...
Loading Chart...
Areas of Expertise:
Thrombin Inhibitors
Antithrombotic Ethers
Heterocyclic Compounds
Aromatic Ether Derivatives
1,2,5-Thiadiazole Ethers
Imidazol-4-yl Compounds
Phenylpropanenitriles
Chemical Preparation
Drug Development
Pharmaceutical Chemistry
Bioactive Compounds
21 patents (USPTO):Explore Patents

Title: The Innovative Journey of Leander Merritt: Pioneering Inventor in Indianapolis, IN

Introduction:

Leander Merritt, a talented inventor based in Indianapolis, IN, has left an indelible mark in the field of pharmaceutical innovations. With an impressive portfolio of 21 patents to his name, Merritt continues to drive advancements in the realm of medical research and development.

Latest Patents:

Merritt's recent patents showcase his expertise in developing groundbreaking pharmaceutical compounds. One such invention includes "Aromatic ether derivatives useful as thrombin inhibitors," which highlights his proficiency in creating compounds that serve as inhibitors of factor Xa and thrombin. Another significant patent is "Antithrombotic ethers," which underscores his dedication to formulating pharmaceutical compositions to combat thrombin-related issues.

Career Highlights:

Currently affiliated with Eli Lilly and Company, Merritt's contributions have significantly impacted the pharmaceutical industry. His role in the company allows him to harness his inventive spirit and drive towards pioneering solutions for complex medical challenges. Merritt's relentless pursuit of innovation has positioned him as a key figure in the pharmaceutical landscape.

Collaborations:

Throughout his career, Merritt has collaborated with esteemed professionals in the field, including John S Ward and Charles A Alt. These partnerships have been instrumental in advancing his inventions and fostering a collaborative environment conducive to innovation.

Conclusion:

In conclusion, Leander Merritt stands as a beacon of creativity and ingenuity in the world of pharmaceutical inventions. His stellar patent portfolio, coupled with his tenure at Eli Lilly and Company, solidifies his reputation as a trailblazer in medical research. Merritt's relentless pursuit of innovation continues to inspire future generations of inventors in the pursuit of pioneering advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…